The House Energy and Commerce Health Subcommittee held a hearing this week on several medical device bills that could be included in the FDA user fee reauthorization. Congress is considering the five-year renewal of user fees negotiated by the FDA and the medical technology and pharmaceutical industries. The subcommittee may add other provisions, but likely only those that enjoy bipartisan support and wouldn’t jeopardize congressional passage of the underlying user fee bill.

BakerHostetler’s “Capitol Hill Healthcare Update” is distributed weekly when Congress is in session. To access previous postings, please see the Health Law Update blog.